Received Oct 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 5N79Z | IM / LA |
Site: Redness at Injection Site-Mild, Additional Details: PATIENT WAS 34 WEEKS PREGNANT AT THE TIME OF VACCINE. PT GOT AREXVY INSTEAD OF ABRYSVO VACCINE. DR IS AWARE AN NO CONCERN TO THE PATIENT OR TO THE BABY. NO SPECIAL MONITORING FOR THE PATIENT BEYOND ROUTINE PRENTAL CARE IS NEEDED.